197 related articles for article (PubMed ID: 30988420)
1. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia.
Rashidi A; Kaiser T; Shields-Cutler R; Graiziger C; Holtan SG; Rehman TU; Wasko J; Weisdorf DJ; Dunny G; Khoruts A; Staley C
Sci Rep; 2019 Apr; 9(1):6083. PubMed ID: 30988420
[TBL] [Abstract][Full Text] [Related]
2. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.
Hueso T; Ekpe K; Mayeur C; Gatse A; Joncquel-Chevallier Curt M; Gricourt G; Rodriguez C; Burdet C; Ulmann G; Neut C; Amini SE; Lepage P; Raynard B; Willekens C; Micol JB; De Botton S; Yakoub-Agha I; Gottrand F; Desseyn JL; Thomas M; Woerther PL; Seguy D
Gut Microbes; 2020 Nov; 12(1):1800897. PubMed ID: 32893715
[TBL] [Abstract][Full Text] [Related]
3. Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia.
Liu X; Zou Y; Zhang Y; Liu L; Duan Y; Zhang A; Zhang X; Zhang R; Zhao B; Li X; Wei T; He H; Gan Y; Wang K; Zhu X
BMC Cancer; 2021 Nov; 21(1):1190. PubMed ID: 34749705
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens.
Frost F; Weiss FU; Sendler M; Kacprowski T; Rühlemann M; Bang C; Franke A; Völker U; Völzke H; Lamprecht G; Mayerle J; Aghdassi AA; Homuth G; Lerch MM
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00232. PubMed ID: 33094959
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
Malard F; Vekhoff A; Lapusan S; Isnard F; D'incan-Corda E; Rey J; Saillard C; Thomas X; Ducastelle-Lepretre S; Paubelle E; Larcher MV; Rocher C; Recher C; Tavitian S; Bertoli S; Michallet AS; Gilis L; Peterlin P; Chevallier P; Nguyen S; Plantamura E; Boucinha L; Gasc C; Michallet M; Dore J; Legrand O; Mohty M
Nat Commun; 2021 May; 12(1):3084. PubMed ID: 34035290
[TBL] [Abstract][Full Text] [Related]
6. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Ajami NJ; Wadsworth WD; Daver NG; Chemaly RF; Marsh L; Ghantoji SS; Pemmaraju N; Garcia-Manero G; Rezvani K; Alousi AM; Wargo JA; Shpall EJ; Futreal PA; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Cancer; 2016 Jul; 122(14):2186-96. PubMed ID: 27142181
[TBL] [Abstract][Full Text] [Related]
7. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota.
De Pietri S; Ingham AC; Frandsen TL; Rathe M; Krych L; Castro-Mejía JL; Nielsen DS; Nersting J; Wehner PS; Schmiegelow K; Hasle H; Pamp SJ; Müller K
Int J Cancer; 2020 Oct; 147(7):1953-1962. PubMed ID: 32115690
[TBL] [Abstract][Full Text] [Related]
9. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
[TBL] [Abstract][Full Text] [Related]
11. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.
Rashidi A; Kaiser T; Graiziger C; Holtan SG; Rehman TU; Weisdorf DJ; Dunny GM; Khoruts A; Staley C
Cancer; 2020 Apr; 126(7):1434-1447. PubMed ID: 31873965
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
[TBL] [Abstract][Full Text] [Related]
13. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.
Robinson S; Peterson CB; Sahasrabhojane P; Ajami NJ; Shelburne SA; Kontoyiannis DP; Galloway-Peña JR
mSphere; 2020 Apr; 5(2):. PubMed ID: 32295867
[TBL] [Abstract][Full Text] [Related]
14. Persistent Gut Microbial Dysbiosis in Children with Acute Lymphoblastic Leukemia (ALL) During Chemotherapy.
Rajagopala SV; Singh H; Yu Y; Zabokrtsky KB; Torralba MG; Moncera KJ; Frank B; Pieper R; Sender L; Nelson KE
Microb Ecol; 2020 May; 79(4):1034-1043. PubMed ID: 31754744
[TBL] [Abstract][Full Text] [Related]
15. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota response to antibiotics is personalized and depends on baseline microbiota.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Microbiome; 2021 Oct; 9(1):211. PubMed ID: 34702350
[TBL] [Abstract][Full Text] [Related]
17. The relevance of intestinal dysbiosis in liver transplant candidates.
Grąt M; Hołówko W; Wronka KM; Grąt K; Lewandowski Z; Kosińska I; Krasnodębski M; Wasilewicz M; Gałęcka M; Szachta P; Zborowska H; Patkowski W; Krawczyk M
Transpl Infect Dis; 2015 Apr; 17(2):174-84. PubMed ID: 25728703
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis.
Rajagopala SV; Yooseph S; Harkins DM; Moncera KJ; Zabokrtsky KB; Torralba MG; Tovchigrechko A; Highlander SK; Pieper R; Sender L; Nelson KE
BMC Genomics; 2016 Aug; 17(1):635. PubMed ID: 27527070
[TBL] [Abstract][Full Text] [Related]
19. Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.
Malfuson JV; Konopacki J; Thepenier C; Eddou H; Foissaud V; de Revel T
Ann Hematol; 2012 Dec; 91(12):1871-7. PubMed ID: 22820971
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
Rattanathammethee T; Tuitemwong P; Thiennimitr P; Sarichai P; Na Pombejra S; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
PLoS One; 2020; 15(10):e0236460. PubMed ID: 33112882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
